Abstract:Despite recent insights gained from the effects of targeted deletion of the Finkel-Biskis-Jinkins osteosarcoma oncogene (c-fos), Spleen focus-forming virus (SFFV) proviral integration 1 (PU.1), microphthalmia- associated transcription factor, NF-kappa B, and nuclear factor of activated cells cytoplasmic 1 (NFATc1) transcription factor genes, the mechanism underlying transcription factors specifying osteoclast (OC) lineage commitment from monocyte/macrophage remains unclear. To characterize the mechanism by which transcription factors regulate OC lineage commitment, we mapped the critical cis-regulatory element in the promoter of cathepsin K (Ctsk), which is expressed specifically in OCs, and found that CCAAT/enhancer binding protein alpha (C/EBP alpha) is the critical cis-regulatory element binding protein. Our results indicate that C/EBP alpha is highly expressed in pre-OCs and OCs. The combined presence of macrophage colony-stimulating factor and receptor activator of NF-kappa B ligand significantly induces high C/EBP alpha expression. Furthermore, C/EBP alpha(-/-) newborn mice exhibited impaired osteoclastogenesis, and a severe osteopetrotic phenotype, but unaffected monocyte/macrophage development. Impaired osteoclastogenesis of C/EBP alpha(-/-) mouse bone marrow cells can be rescued by c-fos overexpression. Ectopic expression of C/EBP alpha in mouse bone marrow cells and monocyte/ macrophage cells, in the absence of receptor activator of NF-kappa B ligand, induces expression of receptor activator of NF-kappa B, c-fos, Nfatc1, and Ctsk, and it reprograms monocyte/ macrophage cells to OC-like cells. Our results demonstrate that C/EBP alpha directly up-regulates c-fos expression. C/EBP alpha(+/-) mice exhibit an increase in bone density compared with C/EBP alpha(+/+) controls. These discoveries establish C/EBP alpha as the key transcriptional regulator of OC lineage commitment, providing a unique therapeutic target for diseases of excessive bone resorption, such as osteoporosis and arthritis.

Transcriptional regulation of bone formation by the osteoblast-specific transcription factor Osx

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Recent Advances of Osterix Transcription Factor in Osteoblast Differentiation and Bone Formation

Transcriptional regulation of bone sialoprotein gene expression by Osx

The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation

Regulation and Role of Transcription Factors in Osteogenesis

Bone Morphogenetic Protein 2 Upregulates Osterix Expression Through Smad Pathway

Trans-activation of Col1a1 Promoter by Osterix During Osteocyte Differentiation

Osterix Acetylation at K307 and K312 Enhances Its Transcriptional Activity and is Required for Osteoblast Differentiation

Site-Specific Function And Regulation Of Osterix In Tooth Root Formation

Osterix Facilitates Osteocytic Communication by Targeting Connexin43

Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation

p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix.

Development of the research of osteoblast special transcription factor Osterix

SOXC are critical regulators of adult bone mass

Synergistic Inhibition of Wnt Pathway by HIF-1α and Osteoblast-Specific Transcription Factor Osterix (osx) in Osteoblasts

Runx2, Osx, and Dspp in Tooth Development.

Molecular mechanism of osteochondroprogenitor fate determination during bone formation.

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

Osterix Overexpression in Mesenchymal Stem Cells Stimulates Healing of Critical-Sized Defects in Murine Calvarial Bone